Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophilic groups in polymers and macromolecules represent electron-rich chemical moieties, such as amino, thiol, and hydroxyl groups, found within biological polymers like DNA and proteins (Berg et al., Biochemistry). These groups are essential for physiological processes, including enzymatic catalysis and the maintenance of structural integrity in cellular components. In pharmacology, these sites are the primary targets for electrophilic drugs, most notably alkylating agents used in cancer therapy (Goodman & Gilman's The Pharmacological Basis of Therapeutics). These drugs form covalent adducts with nucleophilic centers, such as the N7 position of guanine in DNA, to induce cross-linking and trigger apoptosis (National Cancer Institute). However, the ubiquitous nature of these nucleophilic groups across all cellular components presents a major therapeutic challenge. Non-specific reactivity often leads to systemic toxicity, mutagenicity, and the risk of secondary malignancies.
Covalent modification via nucleophilic attack on electrophilic drug centers, leading to DNA alkylation or protein adduct formation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophilic groups in polymers and macromolecules.